
The Schwab U.S. Dividend Equity ETF (SCHD) is popular among retirees for steady income but has shown minimal dividend growth recently. Four blue-chip stocks—AbbVie, Johnson & Johnson, Procter & Gamble, and Coca-Cola—are highlighted as better alternatives due to their faster dividend increases, strong payout coverage, and no fund fees. While SCHD offers diversification and higher initial yield, these individual stocks provide greater long-term income growth potential, though with higher concentration risk. Retirees with a decade or more ahead may benefit more from these stocks' compounding dividend raises compared to SCHD's slower growth.
AbbVie, Johnson & Johnson, Procter & Gamble, and Coca-Cola show mixed trading sentiment on Pluang, with AbbVie fully bought and Johnson & Johnson mostly sold. AbbVie offers a 2.38% dividend yield while Johnson & Johnson yields 1.9%. As of Nov 17, 2026 21:31 WIB, these stocks reflect active interest among investors balancing dividend income and price movements.